Overview
QNT vs Injective is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | QNT | INJ |
|---|---|---|
| Price | $60.55 | $5.13 |
| Market Cap | $879.24M | $490.41M |
| FDV | — | — |
| Volume 24h | $716,611.29 | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 72.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | QNT | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -1.08% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | QNT | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Use the indicator table as a checklist: if momentum and trend align on one asset while the other diverges, relative-value setups become more interesting — still without certainty.
Fundamentals
| Metric | QNT | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
QNT
Injective
Pros and cons
Pros of QNT
- Higher ranking for QNT can translate into tighter spreads on major venues.
- Composite PEPS readings for QNT can surface clearer module agreement during trend phases.
- QNT typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of QNT
- When dominance narratives fade, QNT can lag hotter rotation names.
- Large-cap status for QNT can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on QNT may stay stretched longer than expected in strong trends.
- Regulatory or macro headlines can hit QNT harder simply because it is more visible.
Pros of Injective
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus QNT with Injective can change portfolio factor exposure.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Trend failures on Injective often travel faster than on more established assets.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
Statistically, higher market cap (QNT) often correlates with deeper books, while hotter 24h prints (Injective) can fade. Position sizing should reflect that uncertainty.
AI summary
This AI-assisted summary starts from live PEPS fields. QNT holds market-cap $879.24M and rank #72; Injective shows $490.41M and #99. Where liquidity and flow matter, watch Injective. Where durability matters, watch QNT. AI composite scores (58.20/48.70) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, QNT or Injective?
“Better” depends on horizon and risk. QNT leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, QNT or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both QNT and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.